Zhu, X.-D.; Corona, A.; Maloccu, S.; Tramontano, E.; Wang, S.; Pannecouque, C.; De Clercq, E.; Meng, G.; Chen, F.-E.
Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy. Molecules 2024, 29, 2120.
https://doi.org/10.3390/molecules29092120
AMA Style
Zhu X-D, Corona A, Maloccu S, Tramontano E, Wang S, Pannecouque C, De Clercq E, Meng G, Chen F-E.
Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy. Molecules. 2024; 29(9):2120.
https://doi.org/10.3390/molecules29092120
Chicago/Turabian Style
Zhu, Xuan-De, Angela Corona, Stefania Maloccu, Enzo Tramontano, Shuai Wang, Christophe Pannecouque, Erik De Clercq, Ge Meng, and Fen-Er Chen.
2024. "Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy" Molecules 29, no. 9: 2120.
https://doi.org/10.3390/molecules29092120
APA Style
Zhu, X.-D., Corona, A., Maloccu, S., Tramontano, E., Wang, S., Pannecouque, C., De Clercq, E., Meng, G., & Chen, F.-E.
(2024). Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy. Molecules, 29(9), 2120.
https://doi.org/10.3390/molecules29092120